FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113758265> ?p ?o ?g. }

• W2113758265 endingPage "157" @default.
• W2113758265 startingPage "151" @default.
• W2113758265 abstract "Acellular pertussis (aP) booster immunizations have been recommended for adolescents and older persons to enhance long-term protection and to possibly reduce community transmission of infections.This was a multicenter, randomized, double-blind vaccine trial in which one-half of the subjects received aP vaccine and one-half received hepatitis A vaccine (control subjects). All subjects were observed for almost 2 years for cough illnesses, and all underwent microbiologic and serologic studies for detection of pertussis infection. Immunoglobulin G (IgG) and immunoglobulin A (IgA) antibodies to pertussis toxin, filamentous hemagglutinin, pertactin, and fimbriae 2/3 were measured by enzyme-linked immunosorbent assay in serum samples obtained 1 and 12 months after immunization. Infection rates were determined with a variety of serologic criteria for control and vaccinated subjects. The incidence of prolonged cough illness was ascertained for subjects with and subjects without serologic evidence of infection.Infection rates among control subjects are particularly representative of those in nonimmunized adults. Among control subjects, 0.4%-2.7% had increases in pertussis antibody of various types and degrees over 1 year, and 20%-46% had prolonged cough illnesses during this interval. Pertussis toxin antibody had the greatest specificity for detecting increases in antibody levels. Asymptomatic infections were approximately 5 times more common than clinical illnesses that met a strict clinical and microbiologic case definition. Relative to control subjects, aP-immunized subjects may have fewer increases in the antibody level (i.e., infections), especially for antibodies to fimbriae 2/3 (an antigen not in the vaccine).Pertussis infections in older persons are largely asymptomatic. aP boosters confer protection for adolescents and adults against symptomatic pertussis and likely confer protection against mild and asymptomatic infections, and use of boosters may reduce transmission to others, especially infants." @default.
• W2113758265 created "2016-06-24" @default.
• W2113758265 creator A5009730605 @default.
• W2113758265 creator A5028844100 @default.
• W2113758265 creator A5030664166 @default.
• W2113758265 creator A5032064797 @default.
• W2113758265 creator A5035090584 @default.
• W2113758265 creator A5040781705 @default.
• W2113758265 creator A5045519730 @default.
• W2113758265 creator A5058949337 @default.
• W2113758265 creator A5061538365 @default.
• W2113758265 creator A5079089148 @default.
• W2113758265 creator A5081646689 @default.
• W2113758265 creator A5090332369 @default.
• W2113758265 date "2006-07-15" @default.
• W2113758265 modified "2023-09-26" @default.
• W2113758265 title "<i>Bordetella Pertussis</i>Infections in Vaccinated and Unvaccinated Adolescents and Adults, as Assessed in a National Prospective Randomized Acellular Pertussis Vaccine Trial (APERT)" @default.
• W2113758265 cites W1521057482 @default.
• W2113758265 cites W1970621065 @default.
• W2113758265 cites W1981503203 @default.
• W2113758265 cites W1991910946 @default.
• W2113758265 cites W2007999087 @default.
• W2113758265 cites W2012563370 @default.
• W2113758265 cites W2013050825 @default.
• W2113758265 cites W2023697857 @default.
• W2113758265 cites W2034338815 @default.
• W2113758265 cites W2036897121 @default.
• W2113758265 cites W2048514676 @default.
• W2113758265 cites W2075467516 @default.
• W2113758265 cites W2087640952 @default.
• W2113758265 cites W2103711483 @default.
• W2113758265 cites W2105870164 @default.
• W2113758265 cites W2110232114 @default.
• W2113758265 cites W2112006596 @default.
• W2113758265 cites W2131335414 @default.
• W2113758265 cites W2138259524 @default.
• W2113758265 cites W2140405823 @default.
• W2113758265 cites W2143414315 @default.
• W2113758265 cites W2144677882 @default.
• W2113758265 cites W2149991696 @default.
• W2113758265 cites W2159045466 @default.
• W2113758265 cites W2164635073 @default.
• W2113758265 cites W2171876611 @default.
• W2113758265 cites W4232589663 @default.
• W2113758265 cites W4238475361 @default.
• W2113758265 cites W4241803255 @default.
• W2113758265 doi "https://doi.org/10.1086/504803" @default.
• W2113758265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16779740" @default.
• W2113758265 hasPublicationYear "2006" @default.
• W2113758265 type Work @default.
• W2113758265 sameAs 2113758265 @default.
• W2113758265 citedByCount "107" @default.
• W2113758265 countsByYear W21137582652012 @default.
• W2113758265 countsByYear W21137582652013 @default.
• W2113758265 countsByYear W21137582652014 @default.
• W2113758265 countsByYear W21137582652015 @default.
• W2113758265 countsByYear W21137582652016 @default.
• W2113758265 countsByYear W21137582652017 @default.
• W2113758265 countsByYear W21137582652018 @default.
• W2113758265 countsByYear W21137582652019 @default.
• W2113758265 countsByYear W21137582652020 @default.
• W2113758265 countsByYear W21137582652021 @default.
• W2113758265 countsByYear W21137582652022 @default.
• W2113758265 countsByYear W21137582652023 @default.
• W2113758265 crossrefType "journal-article" @default.
• W2113758265 hasAuthorship W2113758265A5009730605 @default.
• W2113758265 hasAuthorship W2113758265A5028844100 @default.
• W2113758265 hasAuthorship W2113758265A5030664166 @default.
• W2113758265 hasAuthorship W2113758265A5032064797 @default.
• W2113758265 hasAuthorship W2113758265A5035090584 @default.
• W2113758265 hasAuthorship W2113758265A5040781705 @default.
• W2113758265 hasAuthorship W2113758265A5045519730 @default.
• W2113758265 hasAuthorship W2113758265A5058949337 @default.
• W2113758265 hasAuthorship W2113758265A5061538365 @default.
• W2113758265 hasAuthorship W2113758265A5079089148 @default.
• W2113758265 hasAuthorship W2113758265A5081646689 @default.
• W2113758265 hasAuthorship W2113758265A5090332369 @default.
• W2113758265 hasBestOaLocation W21137582651 @default.
• W2113758265 hasConcept C126322002 @default.
• W2113758265 hasConcept C159654299 @default.
• W2113758265 hasConcept C170493617 @default.
• W2113758265 hasConcept C196419574 @default.
• W2113758265 hasConcept C203014093 @default.
• W2113758265 hasConcept C22070199 @default.
• W2113758265 hasConcept C2777582894 @default.
• W2113758265 hasConcept C2779214499 @default.
• W2113758265 hasConcept C2779634000 @default.
• W2113758265 hasConcept C2780801004 @default.
• W2113758265 hasConcept C45189115 @default.
• W2113758265 hasConcept C49773422 @default.
• W2113758265 hasConcept C523546767 @default.
• W2113758265 hasConcept C54355233 @default.
• W2113758265 hasConcept C71924100 @default.
• W2113758265 hasConcept C80631254 @default.
• W2113758265 hasConcept C8439097 @default.
• W2113758265 hasConcept C86803240 @default.
• W2113758265 hasConceptScore W2113758265C126322002 @default.
• W2113758265 hasConceptScore W2113758265C159654299 @default.

• next